Location: Memphis
Synced from ClinicalTrials.gov · August 08, 2026
Clinical studies recruiting near Memphis
Studies with at least one listed site matching this
location on the public registry. Each page explains the study in plain
language, with locations and study-team contacts.
Clinicians: generate a
printable list for your patient →
🔍 Search another city or condition
Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections Phase 4 · St. Jude Children's Research Hospital · Westat · NCT06738407 Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections Phase N/A · St. Jude Children's Research Hospital · Arkansas Children's Hospital Research Institute · NCT03827694 Phase 3, Open-label, Single-dose Study of CSL222 in Adolescent Male Subjects (≥ 12 to < 18 Years of Age) With Severe or Phase 3 · St. Jude Children's Research Hospital · CSL Behring · NCT07080905 Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012) Phase 3 · Baptist Cancer Center ( Site 0101) · Merck Sharp & Dohme LLC · NCT06393374 MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Wi Phase 2 · Baptist Memorial Hospital and Cancer Center-Memphis · National Cancer Institute (NCI) · NCT05564390 A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) G Phase 1/Phase 2 · Saint Jude Children's Research Hospital · National Cancer Institute (NCI) · NCT05099003 Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed Phase 3 · Saint Jude Children's Research Hospital · National Cancer Institute (NCI) · NCT06172296 Feasibility of High Intensity Interval Training in Survivors of Childhood, Adolescent, and Young Adult Hodgkin Lymphoma NA · St. Jude Children's Research Hospital · St. Jude Children's Research Hospital · NCT07222345 Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C Phase 3 · Baptist Memorial Hospital and Cancer Center-Memphis · NRG Oncology · NCT05624996 Study of Oral and Long-Acting Injectable Cabotegravir and Rilpivirine in Virologically Suppressed Children Living With H Phase 1/Phase 2 · Site 6501, St. Jude Children's Research Hospital CRS · National Institute of Allergy and Infectious Diseases (NIAID · NCT05660980 Treatment With Endovascular Intervention for STroke Patients With Existing Disability Phase N/A · Baptist Memorial Hospital · University of Cincinnati · NCT05911568 Two Dose Levels of Privigen in Pediatric CIDP Phase 4 · Le Bonheur Children's Hospital · CSL Behring · NCT03684018 Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission Phase 1/Phase 2 · 6501, St Jude Children's Research Hospital Clinical Research · National Institute of Allergy and Infectious Diseases (NIAID · NCT02140255 A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carbop Phase 3 · Baptist Cancer Center · Hoffmann-La Roche · NCT06793215 Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated C Phase 3 · Baptist Memorial Hospital and Cancer Center-Memphis · Alliance for Clinical Trials in Oncology · NCT07321652 Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML) Phase 3 · St. Jude Children's Research Hospital · PedAL BCU, LLC · NCT05183035 A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma Phase 2 · Saint Jude Children's Research Hospital · Children's Oncology Group · NCT06368817 A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease Phase 1 · Regional One Health · Fate Therapeutics · NCT06308978 A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma Phase 2/Phase 3 · Saint Jude Children's Research Hospital · National Cancer Institute (NCI) · NCT05691478 CD123-Directed T-Cell Therapy for Acute Myelogenous Leukemia (CATCHAML) Phase 1 · St Jude Children's Research Hospital · St. Jude Children's Research Hospital · NCT04318678 A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011) Phase 3 · St. Jude Children's Research Hospital ( Site 0026) · Merck Sharp & Dohme LLC · NCT07044297 Pharmacogenetic Determinants Of Treatment Response In Children Phase N/A · St. Jude Children's Research Hospital · St. Jude Children's Research Hospital · NCT00730678 Prospective Evaluation of Complex Adult Spinal Deformity (CAD) Treated With Minimally Invasive Surgery Phase N/A · Semmes-Murphey · International Spine Study Group Foundation · NCT04885244 Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients Phase N/A · Baptist Memorial Hospital and Cancer Center - Memphis · PrECOG, LLC. · NCT06538038 A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangement Phase 1/Phase 2 · Baptist Memorial Hospital Baptist Cancer Center · Turning Point Therapeutics, Inc. · NCT03093116 A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy Phase N/A · Mid South Retina Associates · Astellas Pharma Global Development, Inc. · NCT06779773 CAR T CELL Therapy for Pediatric, Adolescent and Young Adult Patients With CD19-Positive Leukemia Phase 2 · St. Jude Children's Research Hospital · St. Jude Children's Research Hospital · NCT06847269 A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT Phase 2 · Saint Jude Children's Research Hospital · Children's Oncology Group · NCT04322318 A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS) Phase 3 · Le Bonheur Childrens Outpatient Center - PIN · Longboard Pharmaceuticals · NCT06660394 A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants Wit Phase 3 · Baptist Cancer Center ( Site 4049) · Merck Sharp & Dohme LLC · NCT06077760
Look up another city
Look up another condition